Chemotherapy

• Cannabinoids and triple-negative breast cancer treatment (03 Sep 2024)
  
• Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery (02 Sep 2024)
  
• Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway (30 Aug 2024)
  
• Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells (29 Aug 2024)
  
• Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (20 Aug 2024)
  
• Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review (20 Aug 2024)
  
• Antitumor Cannabinoid Chemotypes: Structural Insights (19 Aug 2024)
  
• Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy (13 May 2024)
  
• Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
  
• Medical Cannabis in Pediatric Oncology: Friend or Foe? (05 Aug 2022)
  
• Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review (31 Jul 2022)
  
• Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review - Journal of Cannabis Research (26 Jul 2022)
  
• Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer - Journal of Cannabis Research (26 Jul 2022)
  
• Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo (25 Jul 2022)
  
• Encouraging Cancer Research (21 Jul 2022)
  
• Customized Phytocannabinoid Profiles: A Novel Source of Precision Therapeutics for Specific Cancer Subtypes? (18 Jul 2022)